An investor consortium including WhiteOak Capital Management, Siguler Guff, and Creador has acquired approximately 10% of La Renon Healthcare, valuing the Ahmedabad-based pharmaceutical company at ₹11,000 crore ($1.2 billion). The deal involves stake dilution by promoters Pankaj Singh and family, and existing investors like Peak XV Partners and A91 Partners. Creador is acquiring 7% for ₹770 crore, while WhiteOak Capital and Siguler Guff jointly purchase 3% for ₹330 crore.